This article is available to Insider Pro subscribers only. Sign in or register to be an Insider Pro and access ALL LOCKED articles.
New Findings from National Health Insurance Service Ilsan Hospital in the Area of Kidney Transplants Reported (Serum Proteomic Profiles of Microvascular Inflammation in Donor-specific Antibody-negative and C4d-negative in Kidney Transplantation): Transplant Medicine – Kidney Transplants
Universal Insurance (NYSE:UVE) Posts Earnings Results, Beats Expectations By $0.22 EPS
Username
Password
Remember Me
New Findings from National Health Insurance Service Ilsan Hospital in the Area of Kidney Transplants Reported (Serum Proteomic Profiles of Microvascular Inflammation in Donor-specific Antibody-negative and C4d-negative in Kidney Transplantation): Transplant Medicine – Kidney Transplants
Universal Insurance (NYSE:UVE) Posts Earnings Results, Beats Expectations By $0.22 EPS
Advisor News
- Could a narrower focus help grow your practice?
- U.S. debt hits $40 trillion: how to support concerned clients
- Flourish brings private-bank-like cash solution to MassMutual’s network
- Majority of Americans concerned recent market highs are unsustainable
- GLP-1 users choose between medication and retirement saving
More Advisor NewsAnnuity News
- MassMutual Expands Lending Options With New Secured Credit Line
- Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
- Insurer proposes $1.1M deal to resolve CA teachers’ annuity fee lawsuit
- IMOs get frustrated with slow carrier adoption of faster technology
- New class-action lawsuit targets Delaware Life over annuity disclosures
More Annuity NewsHealth/Employee Benefits News
Life Insurance News